-
Rasmussen Family funds research into underlying causes of colorectal cancer
Anna and Neil Rasmussen are no strangers to medical research in the quest to find answers to chronic illness—one of their children had been living with ulcerative colitis since she was seven years old.
-
IMS grants drive innovative multiple myeloma research
The International Myeloma Society (IMS) recently awarded three Dana-Farber scientists grants totaling $525,000 to promote research on the blood cancer multiple myeloma.
-
Gift to ovarian cancer inspired by story of research
In early 2022, Dr. Jean Kasmer read a story in Impact about an ovarian cancer survivor who gave to support the research of Ursula Matulonis, MD, chief of the division of Gynecologic Oncology and the Brock-Wilson Family Chair at Dana-Farber.
-
Johnston gift paves the way for a novel ovarian cancer clinical trial
Debbie Johnston is dedicated to supporting causes that are close to her heart, and Dana-Farber Cancer Institute’s ovarian cancer research is one such cause.
-
PBTF accelerates research to better treat pediatric brain tumors
Since 1991, Pediatric Brain Tumor Foundation (PBTF) has helped patients and families cope with a brain cancer diagnosis, offering financial, logistical, and emotional support.
-
Feenys invest in new treatments for advanced prostate cancer
In his 12 years as a prostate cancer patient, Chuck Feeny has learned quite a lot about the disease and how to navigate it. He takes each day in stride, every setback, every bit of good news and bad.
-
Dana-Farber team defies cancer in ASICS Falmouth Road Race
On Aug. 21, more than 330 members of Dana-Farber’s team ran seven miles along the scenic Cape Cod coastline for the 50th running of the ASICS Falmouth Road Race.







